SCHEMBL7375863

SCHEMBL7375863

[CH2]c1ccc2c(c1)N=NC2=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2270251 0.69 ALDH1A1 (0.46)
SCHEMBL94097 0.67 MEN1 (0.41)
SCHEMBL2299303 0.62 MAOA (0.43)
SCHEMBL2268131 0.61 MAOA (0.43)
SCHEMBL27632036 0.59 PPOX (0.56)
SCHEMBL2970333 0.59 NPC1 (0.50)
SCHEMBL360245 0.59 MEN1 (0.57)
SCHEMBL1665290 0.58 MAOA (0.43)
SCHEMBL8134807 0.57 GSTP1 (0.43)
SCHEMBL26128819 0.57 MEN1 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997008150-A1 SUBSTITUTED CYCLIC UREAS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-06 WO claimed
US-5763469-A Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-06-09 US disclosed
WO-1997008150-A1 SUBSTITUTED CYCLIC UREAS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-06 WO disclosed